TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0170
+0.0010 (6.25%)
At close: Mar 24, 2026
TrivarX Market Cap
TrivarX has a market cap or net worth of 19.61 million as of March 24, 2026. Its market cap has increased by 147.31% in one year.
Market Cap
19.61M
Enterprise Value
16.29M
Revenue
-95.36K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 19.61M, an increase of 69.53%. That is a compound annual growth rate of 2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 18.46M | -15.79% |
| Dec 31, 2025 | 21.92M | 194.71% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beamtree Holdings | 42.14M |
| Vitasora Health | 40.73M |
| Emyria | 32.26M |
| PainChek | 31.35M |
| ImExHS | 21.35M |
| Resonance Health | 19.56M |
| Pathkey.AI | 15.78M |
| Adheris Health | 12.74M |